Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$250.76
6.752.77%
al cierre: -
$250.39
-0.37-0.15%
After hour: 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Salesforce Inc ha un obiettivo di prezzo di consenso pari a $336.32, stabilito in base alle ultime valutazioni degli analisti di 35. Le ultime 3 valutazioni degli analisti sono state rilasciate da Macquarie, Bernstein y Baird il septiembre 5, 2025, septiembre 4, 2025 y septiembre 4, 2025. Con un obiettivo di prezzo medio di $265.33 tra le Macquarie, Bernstein y Baird, c'è un implicito 5.97% upside per Salesforce Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Macquarie
Bernstein
Baird
Deutsche Bank
BMO Capital
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Salesforce
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/05/2025 | -0.16% | Macquarie | $290 → $250 | Maintains | Neutral | |||
09/04/2025 | -11.74% | Bernstein | $255 → $221 | Maintains | Underperform | |||
09/04/2025 | 29.8% | Baird | $365 → $325 | Maintains | Outperform | |||
09/04/2025 | 35.79% | Deutsche Bank | $400 → $340 | Maintains | Buy | |||
09/04/2025 | 11.83% | BMO Capital | $335 → $280 | Maintains | Outperform | |||
09/04/2025 | 15.82% | Macquarie | $290 → $290 | Maintains | Neutral | |||
09/04/2025 | -0.16% | RBC Capital | $275 → $250 | Maintains | Sector Perform | |||
09/04/2025 | 5.83% | Wells Fargo | $275 → $265 | Maintains | Equal-Weight | |||
09/04/2025 | 29.8% | Cantor Fitzgerald | $325 → $325 | Reiterates | Overweight → Overweight | |||
09/04/2025 | 19.81% | Canaccord Genuity | $350 → $300 | Maintains | Buy | |||
09/04/2025 | 59.75% | Keybanc | $440 → $400 | Maintains | Overweight | |||
09/04/2025 | 45.77% | JP Morgan | $380 → $365 | Maintains | Overweight | |||
09/04/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
09/04/2025 | 25.8% | Piper Sandler | $335 → $315 | Maintains | Overweight | |||
09/02/2025 | 71.73% | JMP Securities | $430 → $430 | Reiterates | Market Outperform → Market Outperform | |||
09/02/2025 | 61.75% | Morgan Stanley | $404 → $405 | Maintains | Overweight | |||
08/28/2025 | 29.8% | Cantor Fitzgerald | $325 → $325 | Reiterates | Overweight → Overweight | |||
08/26/2025 | 47.77% | Oppenheimer | $315 → $370 | Maintains | Outperform | |||
08/26/2025 | 29.8% | B of A Securities | $350 → $325 | Maintains | Buy | |||
08/18/2025 | 3.84% | UBS | $300 → $260 | Maintains | Neutral | |||
08/18/2025 | 9.83% | RBC Capital | $275 → $275 | Reiterates | Sector Perform → Sector Perform | |||
08/18/2025 | 26.2% | Barclays | $347 → $316 | Maintains | Overweight | |||
08/15/2025 | -10.14% | DA Davidson | $225 → $225 | Upgrade | Underperform → Neutral | |||
08/14/2025 | 39.78% | Mizuho | $380 → $350 | Maintains | Outperform | |||
08/13/2025 | 29.8% | Stifel | $375 → $325 | Maintains | Buy | |||
07/16/2025 | 71.73% | JMP Securities | $430 → $430 | Reiterates | Market Outperform → Market Outperform | |||
07/14/2025 | 9.83% | RBC Capital | $275 → $275 | Maintains | Sector Perform | |||
07/11/2025 | 71.73% | JMP Securities | $430 → $430 | Reiterates | Market Outperform → Market Outperform | |||
07/10/2025 | 33.79% | BMO Capital | $350 → $335 | Maintains | Outperform | |||
06/26/2025 | 29.8% | Cantor Fitzgerald | $325 → $325 | Reiterates | Overweight → Overweight | |||
06/20/2025 | 29.8% | Cantor Fitzgerald | $325 → $325 | Reiterates | Overweight → Overweight | |||
06/10/2025 | 47.77% | Oppenheimer | $370 → $370 | Reiterates | Outperform → Outperform | |||
06/03/2025 | 29.8% | Cantor Fitzgerald | → $325 | Initiates | → Overweight | |||
05/30/2025 | 17.82% | Citigroup | $320 → $295 | Maintains | Neutral | |||
05/30/2025 | 23.41% | Stephens & Co. | $311 → $309 | Maintains | Equal-Weight | |||
05/29/2025 | 9.83% | Wells Fargo | $255 → $275 | Maintains | Equal-Weight | |||
05/29/2025 | 33.79% | Piper Sandler | $315 → $335 | Maintains | Overweight | |||
05/29/2025 | 47.77% | Oppenheimer | $380 → $370 | Maintains | Outperform | |||
05/29/2025 | 58.15% | Northland Capital Markets | $423 → $396 | Maintains | Outperform | |||
05/29/2025 | 61.35% | Morgan Stanley | $393 → $404 | Maintains | Overweight | |||
05/29/2025 | 38.58% | Barclays | $425 → $347 | Maintains | Overweight | |||
05/29/2025 | -10.14% | DA Davidson | $200 → $225 | Maintains | Underperform | |||
05/29/2025 | 53.76% | Goldman Sachs | $340 → $385 | Maintains | Buy | |||
05/29/2025 | 1.84% | Bernstein | $243 → $255 | Maintains | Underperform | |||
05/29/2025 | 9.83% | RBC Capital | $420 → $275 | Downgrade | Outperform → Sector Perform | |||
05/29/2025 | 27.8% | WestPark Capital | $320 → $320 | Reiterates | Buy → Buy | |||
05/29/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/28/2025 | -20.12% | DA Davidson | $200 → $200 | Maintains | Underperform | |||
05/28/2025 | 39.78% | Canaccord Genuity | $400 → $350 | Maintains | Buy | |||
05/28/2025 | 27.8% | WestPark Capital | $320 → $320 | Reiterates | Buy → Buy | |||
05/28/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/27/2025 | 35.79% | Goldman Sachs | $340 → $340 | Reiterates | Buy → Buy | |||
05/27/2025 | 19.81% | UBS | $320 → $300 | Maintains | Neutral | |||
05/27/2025 | 39.78% | BMO Capital | $367 → $350 | Maintains | Outperform | |||
05/23/2025 | 27.8% | Citigroup | $335 → $320 | Maintains | Neutral | |||
05/21/2025 | 27.8% | UBS | $340 → $320 | Maintains | Neutral | |||
05/15/2025 | 51.76% | Mizuho | $425 → $380 | Maintains | Outperform | |||
04/30/2025 | 27.8% | WestPark Capital | $320 → $320 | Reiterates | Buy → Buy | |||
04/25/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
04/24/2025 | 35.79% | Goldman Sachs | $400 → $340 | Maintains | Buy | |||
04/23/2025 | 25.8% | Piper Sandler | $400 → $315 | Maintains | Overweight | |||
04/22/2025 | 1.84% | Wells Fargo | $310 → $255 | Maintains | Equal-Weight | |||
04/21/2025 | — | Guggenheim | — | Upgrade | Sell → Neutral | |||
04/21/2025 | -20.12% | DA Davidson | → $200 | Downgrade | Neutral → Underperform | |||
04/16/2025 | 56.96% | Morgan Stanley | — | $405 → $393 | Maintains | Overweight | ||
04/14/2025 | -0.16% | DA Davidson | $275 → $250 | Maintains | Neutral | |||
03/31/2025 | 49.77% | Jefferies | $425 → $375 | Maintains | Buy | |||
03/20/2025 | 27.8% | Macquarie | $320 → $320 | Maintains | Neutral | |||
03/19/2025 | — | Stephens & Co. | — | Initiates | → Equal-Weight | |||
03/17/2025 | 37.79% | Scotiabank | $400 → $345 | Maintains | Sector Outperform | |||
03/08/2025 | 59.75% | Goldman Sachs | $400 → $400 | Maintains | Buy | |||
02/28/2025 | 33.79% | Citigroup | $350 → $335 | Maintains | Neutral | |||
02/27/2025 | 35.79% | UBS | $360 → $340 | Maintains | Neutral | |||
02/27/2025 | 59.75% | Goldman Sachs | $400 → $400 | Maintains | Buy | |||
02/27/2025 | 59.75% | Canaccord Genuity | $415 → $400 | Maintains | Buy | |||
02/27/2025 | 19.81% | Loop Capital | $330 → $300 | Maintains | Hold | |||
02/27/2025 | 9.83% | DA Davidson | $300 → $275 | Maintains | Neutral | |||
02/27/2025 | 59.75% | Scotiabank | $440 → $400 | Maintains | Sector Outperform | |||
02/27/2025 | 27.8% | Macquarie | $370 → $320 | Maintains | Neutral | |||
02/27/2025 | 46.57% | BMO Capital | $375 → $367 | Maintains | Outperform | |||
02/27/2025 | -1.35% | Guggenheim | $247 → $247 | Reiterates | Sell → Sell | |||
02/27/2025 | 49.77% | Stifel | $425 → $375 | Maintains | Buy | |||
02/27/2025 | 59.75% | Baird | $430 → $400 | Maintains | Outperform | |||
02/27/2025 | 51.76% | Oppenheimer | $415 → $380 | Maintains | Outperform | |||
02/27/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
02/27/2025 | 59.75% | B of A Securities | $440 → $400 | Maintains | Buy | |||
02/27/2025 | 59.75% | Piper Sandler | $405 → $400 | Maintains | Overweight | |||
02/27/2025 | 23.81% | Wells Fargo | $345 → $310 | Maintains | Equal-Weight | |||
02/25/2025 | 39.78% | Citigroup | $390 → $350 | Maintains | Neutral | |||
02/24/2025 | 79.72% | Citizens Capital Markets | $450 → $450 | Reiterates | Market Outperform → Market Outperform | |||
02/21/2025 | 49.77% | BMO Capital | $425 → $375 | Maintains | Outperform | |||
02/19/2025 | 31.79% | Loop Capital | $360 → $330 | Maintains | Hold | |||
02/10/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
02/06/2025 | 59.75% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
01/17/2025 | 59.75% | TD Cowen | $380 → $400 | Upgrade | Hold → Buy | |||
01/08/2025 | 59.75% | Needham | $375 → $400 | Maintains | Buy | |||
01/06/2025 | -1.35% | Guggenheim | $247 → $247 | Downgrade | Neutral → Sell | |||
12/18/2024 | 47.77% | Macquarie | $370 → $370 | Maintains | Neutral | |||
12/18/2024 | 79.72% | JMP Securities | $450 → $450 | Reiterates | Market Outperform → Market Outperform | |||
12/18/2024 | 69.74% | Wedbush | $425 → $425 | Reiterates | Outperform → Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Salesforce (CRM)?
El último precio objetivo de Salesforce (NYSE:CRM) fue comunicado por Macquarie el septiembre 5, 2025. La firma de analistas fijó un precio objetivo para $250.00 que espera CRM a fall dentro de 12 meses (un posible -0.16% downside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Salesforce (CRM)?
La última calificación de analistas para Salesforce (NYSE:CRM) fue proporcionada por Macquarie, y Salesforce mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Salesforce (CRM)?
La última revisión al alza de Salesforce Inc se produjo en agosto 15, 2025, cuando DA Davidson elevó su precio objetivo a $225. DA Davidson anteriormente tenía an underperform para Salesforce Inc.
¿Cuándo fue la última revisión a la baja de Salesforce (CRM)?
La última revisión a la baja de Salesforce Inc se produjo en mayo 29, 2025, cuando RBC Capital cambió su precio objetivo de $420 a $275 para Salesforce Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Salesforce (CRM)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Salesforce, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Salesforce se registró el septiembre 5, 2025, por lo que la próxima calificación estará disponible en torno al septiembre 5, 2026.
¿Es correcta la calificación de los analistas sobre Salesforce (CRM)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Salesforce (CRM) fue un mantuvo con un precio objetivo de $290.00 a $250.00. El precio actual al que cotiza Salesforce (CRM) es de $250.39, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.